about
Effectiveness of an individual, online e-learning program about sexually transmitted infections: a prospective cohort studyBarriers to GPs' use of evidence-based medicine: a systematic reviewManagement of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing.Sublingual nitroglycerin used in routine tilt testing provokes a cardiac output-mediated vasovagal response.Hemodynamic effects of leg crossing and skeletal muscle tensing during free standing in patients with vasovagal syncope.Clinical factors associated with quality of life in patients with transient loss of consciousness.Leg crossing with muscle tensing, a physical counter-manoeuvre to prevent syncope, enhances leg blood flow.Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial).Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years.Initial orthostatic hypotension: review of a forgotten condition.Daily, weekly, monthly, and seasonal patterns in the occurrence of vasovagal syncope in an older population.Reliability, validity and responsiveness of the syncope functional status questionnaire.Quality of life within one year following presentation after transient loss of consciousness.Influence of age and gender on the occurrence and presentation of reflex syncope.Steep fall in cardiac output is main determinant of hypotension during drug-free and nitroglycerine-induced orthostatic vasovagal syncope.Genetic aspects of vasovagal syncope: a systematic review of current evidence.Syncope prevalence in the ED compared to general practice and population: a strong selection process.Low creatine kinase is associated with a high population incidence of faintingFainting, emancipation and the 'weak and sensitive' sex.Diagnosing vasovagal syncope based on quantitative history-taking: validation of the Calgary Syncope Symptom Score.Prospective evaluation of non-pharmacological treatment in vasovagal syncope.[Preventing fainting due to needles or blood].Association between psychological complaints and recurrence of vasovagal syncope.Physiologic strategies to prevent fainting responses during or after whole blood donation.Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial).Identifying cardiac syncope based on clinical history: a literature-based model tested in four independent datasets.Priorities for emergency department syncope research.Physical counter-pressure manoeuvres in preventing syncopal recurrence in patients older than 40 years with recurrent neurally mediated syncope: a controlled study from the Third International Study on Syncope of Uncertain Etiology (ISSUE-3)†.Syncope in genotype-negative long QT syndrome family members.Syncope in Brugada syndrome: prevalence, clinical significance, and clues from history taking to distinguish arrhythmic from nonarrhythmic causes.History taking as a diagnostic test in patients with syncope: developing expertise in syncope.Clinical history in management of suspected syncope: A powerful diagnostic tool.Syncope clinical management in the emergency department: a consensus from the first international workshop on syncope risk stratification in the emergency department
P50
Q30846813-DDF564AF-8B16-4B93-BDF3-8C104A50879AQ31071765-3980F6FD-B686-429C-B23D-7F2B2439CA1AQ33148139-9A3EAC19-21E7-40B9-A463-78921A40C9F8Q33151746-DFA66E0A-4247-4E3B-B2CF-F8AD4A36E1DEQ33151909-BEBF058A-AAE8-47F5-88F0-D84D49A7C50CQ33153931-5C68CF47-4E78-4D62-9139-87507AE11BA9Q33154285-54B421F5-F198-4FEB-8B83-FC2D7DE80BACQ33154371-F797ED2B-6634-4FBB-A609-A2292760B0EBQ33154430-AF894149-D822-45D7-91A7-508D5C3335BBQ33154610-E30DCF4A-802C-4323-8A6D-B69B2C69C57CQ33155195-65EE40F8-8FE3-4AD1-8E14-0555C4E8CE2FQ33155315-F3724B6B-9E26-4FD1-80F2-4F3FDF949554Q33155440-DBD09979-BFD4-4F08-AF12-6E30A43480F7Q33156237-DD8467A7-7EE1-4BA3-8F17-08D0569066B2Q33156925-217271F9-0176-4596-9808-F26CD44417EFQ33157027-41CF4E9B-B70B-421F-8D12-3325BA14A957Q33157245-0A10C9FC-C4D6-4ACF-B947-60323FFECC96Q33157439-B17C8DD4-906E-4B12-B03A-35F711B84128Q33157549-2D7FEE6C-EF88-460C-80FE-C1EA0540DE33Q33157707-986C016F-81FE-4CD0-981A-83AD7565E7BFQ33158216-E3B1CC55-46E6-4178-B3BF-7C3927FEB76CQ33158948-88C01151-0F1D-4111-A95A-F15F7B7E643AQ33160012-C935893D-1B0C-4C51-AF1E-4FBC3049A898Q33160115-A5E45E02-F2D5-4A21-9BF5-51C4D96F07ABQ33160239-24AF7AC1-9ECF-4D4A-ACDF-1249692FB331Q33163520-6E4A5856-32E7-4937-B824-88BDFAAAB09DQ33164374-E60B88ED-F8C0-4865-A888-DB102147C635Q33164403-57104386-BE7C-40A3-B711-91AEB492650AQ33164687-1FC5D0E6-342D-4F35-8040-D987CC71332EQ33164862-9C7CEC4A-A58E-4A32-A90E-E9DB9A3E0880Q33165066-BEB2381F-4169-4CFC-8E5A-00969D9C0B67Q33165087-2B777211-152D-42CA-A74A-ACB51203CACBQ33166081-AE4A577A-1879-482B-8A24-D2BC61BAE201
P50
description
onderzoeker
@nl
name
Nynke van Dijk
@ast
Nynke van Dijk
@en
Nynke van Dijk
@es
Nynke van Dijk
@nl
Nynke van Dijk
@sl
type
label
Nynke van Dijk
@ast
Nynke van Dijk
@en
Nynke van Dijk
@es
Nynke van Dijk
@nl
Nynke van Dijk
@sl
prefLabel
Nynke van Dijk
@ast
Nynke van Dijk
@en
Nynke van Dijk
@es
Nynke van Dijk
@nl
Nynke van Dijk
@sl